Evidence map›Paper›PMID 32193800›Full record

ArticleClinical autonomic research : official journal of the Clinical Autonomic Research Society2020

Autonomic dysfunction and phenoconversion in idiopathic REM sleep behavior disorder.

Stuart J McCarter, Tonette L Gehrking, Erik K St Louis, Mariana D Suarez, Bradley F Boeve, Michael H Silber, Phillip A Low, Wolfgang Singer

Open access · greenAbstract read
In one paragraph

Article in Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Predictors of RBD progression and conversion to synucleinopathies.Current neurology and neuroscience reports · 2022
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Autonomic impairment in REM sleep behavior disorder: a potential biomarker of phenoconversion?Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2020
    Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Stuart J McCarterDepartment of Neurology, Mayo Clinic, 200 First Street Southwest, Rochester, MN, 55905, USA.
Tonette L GehrkingDepartment of Neurology, Mayo Clinic, 200 First Street Southwest, Rochester, MN, 55905, USA.
Erik K St LouisDepartment of Neurology, Mayo Clinic, 200 First Street Southwest, Rochester, MN, 55905, USA.
Mariana D SuarezDepartment of Neurology, Mayo Clinic, 200 First Street Southwest, Rochester, MN, 55905, USA.
Bradley F BoeveDepartment of Neurology, Mayo Clinic, 200 First Street Southwest, Rochester, MN, 55905, USA.
Michael H SilberDepartment of Neurology, Mayo Clinic, 200 First Street Southwest, Rochester, MN, 55905, USA.
Phillip A LowDepartment of Neurology, Mayo Clinic, 200 First Street Southwest, Rochester, MN, 55905, USA.
Wolfgang SingerDepartment of Neurology, Mayo Clinic, 200 First Street Southwest, Rochester, MN, 55905, USA. singer.wolfgang@mayo.edu.
Mayo Clinic · USMayo Clinic in Florida · US

Funding

Synucleinopathies – Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic ApproachR01NS092625 · NINDS · MAYO CLINIC ROCHESTER · PI SINGER, WOLFGANG, VEMURI, PRASHANTHI · 2015 to 2025
$6.6M
NINDS NIH HHS R01 NS092625
6 · The paper itself

Abstract

backgroundREM sleep behavior disorder (RBD) is a common finding among patients with synucleinopathies. We aimed to determine the degree of autonomic dysfunction in patients presenting with idiopathic RBD (iRBD), and the predictive value of autonomic dysfunction for phenoconversion to a defined neurodegenerative disease.

methodsWe searched our electronic medical record for patients diagnosed with iRBD who also underwent standardized autonomic function testing within 6 months of iRBD diagnosis, and who had clinical follow-up of at least 3 years following iRBD diagnosis. The composite autonomic severity score (CASS) was derived and compared between phenoconverters and non-converters using chi-square and Wilcoxon rank-sum tests.

resultsWe identified 18 patients who fulfilled inclusion and exclusion criteria. Average age at autonomic testing was 67 ± 6.6 years. Twelve (67%) patients phenoconverted during the follow-up period; six developed Parkinson's disease (PD), and the other six, dementia with Lewy bodies (DLB). Fifteen (83%) patients had at least mild autonomic dysfunction. There were no significant differences between overall converters and non-converters in total CASS or CASS subscores. However, iRBD patients who developed DLB had significantly higher total and cardiovagal CASS scores compared with those who developed PD (p < 0.05), and a trend for higher adrenergic CASS scores compared to those who developed PD and those who did not phenoconvert. DISCUSSION: Autonomic dysfunction was seen in 83% of iRBD patients, and more severe baseline cardiovagal autonomic dysfunction in iRBD was associated with phenoconversion to DLB but not PD. Prospective studies are needed to confirm the value of autonomic testing for predicting phenoconversion and disease phenotype in iRBD.

Indexed as

Neurodegenerative DiseasesParkinson DiseasePrimary DysautonomiasREM Sleep Behavior DisorderSynucleinopathiesHumansAutonomicDementia with Lewy bodiesParkinson’s diseasePhenoconversionREM sleep behavior disorder (RBD)

Identifiers

PMID32193800
PMCPMC7255960
OpenAlexW3011353647

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.